{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:10:41Z","timestamp":1787782241348,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.vaccine.2021.02.067","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T01:01:05Z","timestamp":1615510865000},"page":"C82-C88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S3","title":["Adverse events following immunization: Findings from 2017\/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017\/2018 measles vaccination campaign"],"prefix":"10.1016","volume":"39","author":[{"given":"Ene","family":"Gbenewei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terna","family":"Nomhwange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Taiwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isiaka","family":"Ayodeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabir","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Jean Baptiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nsubuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Braka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9569-5527","authenticated-orcid":false,"given":"Joseph","family":"Oteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Shuaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.02.067_b0005","unstructured":"WHO. Global Manual on surveillance of adverse events following immunization. 2014 [cited 2021 Jan 17];WA 115:Available from: www.who.int."},{"key":"10.1016\/j.vaccine.2021.02.067_b0010","unstructured":"World Health Organization. MODULE 3 \u2013 Vaccine reactions - WHO Vaccine Safety Basics [Internet]. [cited 2020 Sep 22]. Available from: https:\/\/vaccine-safety-training.org\/vaccine-reactions.html."},{"key":"10.1016\/j.vaccine.2021.02.067_b0015","unstructured":"WHO | Measles [Internet]. WHO. World Health Organization; 2018 [cited 2019 Mar 29]. Available from: https:\/\/www.who.int\/immunization\/diseases\/measles\/en\/."},{"key":"10.1016\/j.vaccine.2021.02.067_b0020","unstructured":"Office WHOR. AFRICAN REGIONAL GUIDELINES FOR MEASLES AND RUBELLA SURVEILLANCE WHO Regional Office for Africa. 2015 [cited 2020 Sep 22];(April):1\u201382. Available from: https:\/\/www.afro.who.int\/publications\/who-african-regional-measles-and-rubella-surveillance-guidelines-0."},{"key":"10.1016\/j.vaccine.2021.02.067_b0025","unstructured":"WHO\/Department of Control of Neglected Tropical Diseases. Weekly epidemiological record Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire [Internet]. Vol. 16, Weekly Epidemiological Record. 2018 [cited 2021 Jan 19]. Available from: http:\/\/www.who.int\/wer2018,93,649-660No48."},{"key":"10.1016\/j.vaccine.2021.02.067_b0030","doi-asserted-by":"crossref","unstructured":"Wariri O, Edem B, Nkereuwem E, Nkereuwem OO, Umeh G, Clark E, et al. Tracking coverage, dropout and multidimensional equity gaps in immunisation systems in West Africa, 2000-2017. BMJ Glob Heal [Internet]. 2019 [cited 2021 Jan 16];4:1713. Available from: http:\/\/gh.bmj.com\/.","DOI":"10.1136\/bmjgh-2019-001713"},{"key":"10.1016\/j.vaccine.2021.02.067_b0035","unstructured":"World Health Organization. Weekly epidemiological record Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire. 2018 [cited 2021 Jan 16]; Available from: http:\/\/www.who.int\/wer2018,93,649-660No48."},{"issue":"3","key":"10.1016\/j.vaccine.2021.02.067_b0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/1118-8561.192394","article-title":"Pattern of adverse events following immunization in nourished and malnourished infants in Kano, North-Western Nigeria","volume":"19","author":"Lawan","year":"2016","journal-title":"Sahel Med J."},{"key":"10.1016\/j.vaccine.2021.02.067_b0045","unstructured":"WHO\/UNICEF. Nigeria\u00a0: WHO and UNICEF estimates of immunization coverage\u00a0: 2019 revision [Internet]. 201Available from: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/nga.pdf."},{"key":"10.1016\/j.vaccine.2021.02.067_b0050","doi-asserted-by":"crossref","unstructured":"Ibrahim BS, Usman R, Mohammed Y, Datti Z, Okunromade O, Abubakar AA, et al. Burden of measles in Nigeria: a five-year review of casebased surveillance data, 2012-2016. Pan Afr Med J [Internet]. 2019 [cited 2021 Jan 16];32(Suppl 1):5. Available from: \/pmc\/articles\/PMC6445333\/?report=abstract.","DOI":"10.11604\/pamj.supp.2019.32.1.13564"},{"key":"10.1016\/j.vaccine.2021.02.067_b0055","unstructured":"World Bank. Population, total - Nigeria | Data [Internet]. [cited 2021 Jan 16]. Available from: https:\/\/data.worldbank.org\/indicator\/SP.POP.TOTL?locations=NG."},{"key":"10.1016\/j.vaccine.2021.02.067_b0060","unstructured":"Kabir Mawashi Y, Gerald Etapelong S, Anthony O, Hamisu Abdullahi W, Becki TN, Joseph OA, et al. Trend analysis of the cases of adverse event following immunization (AEFI) reported In Nigeria between 2011 and 2018. World J Pharm Res [Internet]. 2020 [cited 2021 Jan 16];9. Available from: www.wjpr.net."},{"issue":"1","key":"10.1016\/j.vaccine.2021.02.067_b0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/njbcs.njbcs_18_17","article-title":"Knowledge, perception and reporting attitude of adverse effects following immunization among primary healthcare workers in sabon gari local government area Zaria, Kaduna state, Nigeria","volume":"15","author":"Mohammed","year":"2018","journal-title":"Niger J Basic Clin Sci."},{"issue":"4","key":"10.1016\/j.vaccine.2021.02.067_b0070","first-page":"300","article-title":"Mass Measles Vaccination Campaign in Aila Cyclone-Affected Areas of West Bengal, India: An In-depth Analysis and Experiences","volume":"36","author":"Mallik","year":"2011","journal-title":"Iran J Med Sci."},{"key":"10.1016\/j.vaccine.2021.02.067_b0075","unstructured":"WHO. World Health Organization Vaccination Coverage Cluster Surveys [Internet]. WHO. World Health Organization; 2019 [cited 2020 Jun 11]. Available from: https:\/\/www.who.int\/immunization\/documents\/who_ivb_18.09\/en\/."},{"key":"10.1016\/j.vaccine.2021.02.067_b0080","doi-asserted-by":"crossref","unstructured":"Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, Emiroglu N. Supplementary immunization activities to achieve measles elimination: Experience of the European region. J Infect Dis [Internet]. 2011 [cited 2021 Jan 16];204(SUPPL. 1). Available from: https:\/\/academic.oup.com\/jid\/article\/204\/suppl_1\/S343\/2192548.","DOI":"10.1093\/infdis\/jir074"},{"key":"10.1016\/j.vaccine.2021.02.067_b0085","doi-asserted-by":"crossref","unstructured":"Masuka JT, Khoza S. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase\u00ae from 1997 to 20BMC Public Health [Internet]. 2019 Dec 27 [cited 2021 Jan 16];19(1):1166. Available from: https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-7482-x.","DOI":"10.1186\/s12889-019-7482-x"},{"issue":"5","key":"10.1016\/j.vaccine.2021.02.067_b0090","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1590\/S0080-62342011000500014","article-title":"A pr\u00e1tica da enfermagem frente aos eventos adversos p\u00f3s-vacina\u00e7\u00e3o","volume":"45","author":"Bisetto","year":"2011","journal-title":"Rev da Esc Enferm da USP."},{"key":"10.1016\/j.vaccine.2021.02.067_b0095","unstructured":"Lhl B. Nursing practice in view of adverse events following vaccination."},{"issue":"5","key":"10.1016\/j.vaccine.2021.02.067_b0100","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1080\/21645515.2015.1017694","article-title":"Best vaccination practice and medically attended injection site events following deltoid intramuscular injection","volume":"11","author":"Cook","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"27\u201330","key":"10.1016\/j.vaccine.2021.02.067_b0105","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1016\/S0264-410X(03)00403-1","article-title":"A simple mistake responsible for 153 cases of muscular cold abscesses","volume":"21","author":"Arshi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.067_b0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.11604\/pamj.2017.28.308.12730","article-title":"Evaluation of the adverse events following immunizations surveillance system in Harare City, Zimbabwe, 2016: a descriptive cross sectional study","volume":"28","author":"Zvanaka","year":"2017","journal-title":"Pan Afr Med J"},{"issue":"1","key":"10.1016\/j.vaccine.2021.02.067_b0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3185\/pathexo3182","article-title":"Post-vaccinal adverse effects monitoring during national campaign of vaccination against measles in C\u00f4te d\u2019Ivoire","volume":"102","author":"Die-Kacou","year":"2009","journal-title":"Bull Soc Pathol Exot"},{"issue":"12","key":"10.1016\/j.vaccine.2021.02.067_b0120","first-page":"1395","article-title":"Evaluation of vaccine cold chain in urban health centers of municipal corporation of surat city, Western India","volume":"4","author":"Naik","year":"2013","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.vaccine.2021.02.067_b0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13104-015-1257-y","article-title":"Factors associated with the exposure of vaccines to adverse temperature conditions: the case of North West region, Cameroon","volume":"8","author":"Yakum","year":"2015","journal-title":"BMC Res Notes."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21002589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21002589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:05:25Z","timestamp":1759403125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21002589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":25,"alternative-id":["S0264410X21002589"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events following immunization: Findings from 2017\/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017\/2018 measles vaccination campaign","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}